Longbio Pharma (Suzhou) Co., Ltd. clinical trials
The registry lists 3 studies whose lead sponsor is Longbio Pharma (Suzhou) Co., Ltd.. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 12, 2026.
Our grouping of 1 registry name, not the registry’s. See them and correct one ↓
- 3studies on the registry
- 3open to participants now
- 1reach primary completion within a year
Get an email when these change. Save the Longbio Pharma (Suzhou) Co., Ltd. studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
What it is testing
The drugs Longbio Pharma (Suzhou) Co., Ltd.’s studies test, most open studies first — 2 drugs with a page of their own. Each count opens the studies in search.
Open now Not open: under way, finished or stopped
Coming up
1 of Longbio Pharma (Suzhou) Co., Ltd.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.
Phase 3 Other phases
- NNov ’26’26
- DDec
- JJan ’27’27
- FFeb
- MMar
- AApr
- MMay
- JJun
- 1JJul
- AAug
- SSep
- OOct
- NNov
The study
Add it to your calendar (.ics) → With an account.
All 3 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Open now3100%
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Longbio Pharma (Suzhou) Co., Ltd..
- Longbio Pharma (Suzhou) Co., Ltd.3 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 3 of 3.
- Efficacy, Safety and Pharmacokinetics of LP-003 in Peanut Allergic PatientsNot yet recruitingNCT07785063Phase 2
- A Study to Evaluate the Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Characteristics of LP-003 Injection in Participants With Wheat AllergyNot yet recruitingNCT07816432Phase 2
- Efficacy and Safety of LP-005 Injection in Patients With Moderate-to-Severe PeriodontitisNot yet recruitingNCT07603713Phase 2